The Implementation of a PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) Program in Portugal
Keywords:Aerosols/administration & dosage, Antineoplastic Agents/administration & dosage, Hyperthermic Intraperitoneal Chemotherapy, Peritoneal Neoplasms/drug therapy
Sindayigaya R, Dogan C, Demtröder CR, Fischer B, Karam E, Buggisch JR, et al. Clinical outcome for patients managed with low-dose cisplatin and doxorubicin delivered as pressurized intraperitoneal aerosol chemotherapy for unresectable peritoneal metastases of gastric cancer. Ann Surg Oncol. 2022;29:112-23. DOI: https://doi.org/10.1245/s10434-021-10860-y
Jacquet P, Sugarbaker PH. Peritoneal-plasma barrier. Cancer Treat Res. 1996;82:53-63. DOI: https://doi.org/10.1007/978-1-4613-1247-5_4
Solaß W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012;26:1849-55. DOI: https://doi.org/10.1007/s00464-012-2148-0
Ellebæk SB, Graversen M, Detlefsen S, Lundell L, Fristrup CW, Pfeiffer P, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients. Pleura Peritoneum. 2020;5:20200109. DOI: https://doi.org/10.1515/pp-2020-0109
Mortensen MB, Glehen O, Horvath P, Hübner M, Hyung-Ho K, Königsrainer A, et al. The ISSPP PIPAC database: design, process, access, and first interim analysis. Pleura Peritoneum. 2021;6:91. DOI: https://doi.org/10.1515/pp-2021-0108
How to Cite
Copyright (c) 2022 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.